The immune response to the iodide transporter

C. Spitzweg, J. C. Morris

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

In addition to physiologic, diagnostic, and therapeutic implications, the recently cloned and characterized sodium iodide symporter (NIS) also may play an important role in the pathogenesis of autoimmune thyroid disease. Sodium iodide symporter expression patterns characteristically are changed in autoimmune thyroid disease, including Graves' disease and Hashimoto's thyroiditis, which may be caused, in part, by the regulation of sodium iodide symporter expression of cytokines involved in the pathogenesis of autoimmune thyroid disease. Further, there is increasing evidence that NIS-directed antibodies are present in sera from patients with autoimmune thyroid disease, and these antibodies also may affect NIS functional activity.

Original languageEnglish (US)
Pages (from-to)389-398
Number of pages10
JournalEndocrinology and Metabolism Clinics of North America
Volume29
Issue number2
StatePublished - 2000

Fingerprint

Thyroid Diseases
Iodides
Autoimmune Diseases
Hashimoto Disease
Antibodies
Graves Disease
Cytokines
Serum
sodium-iodide symporter
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The immune response to the iodide transporter. / Spitzweg, C.; Morris, J. C.

In: Endocrinology and Metabolism Clinics of North America, Vol. 29, No. 2, 2000, p. 389-398.

Research output: Contribution to journalReview article

Spitzweg, C. ; Morris, J. C. / The immune response to the iodide transporter. In: Endocrinology and Metabolism Clinics of North America. 2000 ; Vol. 29, No. 2. pp. 389-398.
@article{94a3e10573b442cfbf112360b5dfbf8b,
title = "The immune response to the iodide transporter",
abstract = "In addition to physiologic, diagnostic, and therapeutic implications, the recently cloned and characterized sodium iodide symporter (NIS) also may play an important role in the pathogenesis of autoimmune thyroid disease. Sodium iodide symporter expression patterns characteristically are changed in autoimmune thyroid disease, including Graves' disease and Hashimoto's thyroiditis, which may be caused, in part, by the regulation of sodium iodide symporter expression of cytokines involved in the pathogenesis of autoimmune thyroid disease. Further, there is increasing evidence that NIS-directed antibodies are present in sera from patients with autoimmune thyroid disease, and these antibodies also may affect NIS functional activity.",
author = "C. Spitzweg and Morris, {J. C.}",
year = "2000",
language = "English (US)",
volume = "29",
pages = "389--398",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - The immune response to the iodide transporter

AU - Spitzweg, C.

AU - Morris, J. C.

PY - 2000

Y1 - 2000

N2 - In addition to physiologic, diagnostic, and therapeutic implications, the recently cloned and characterized sodium iodide symporter (NIS) also may play an important role in the pathogenesis of autoimmune thyroid disease. Sodium iodide symporter expression patterns characteristically are changed in autoimmune thyroid disease, including Graves' disease and Hashimoto's thyroiditis, which may be caused, in part, by the regulation of sodium iodide symporter expression of cytokines involved in the pathogenesis of autoimmune thyroid disease. Further, there is increasing evidence that NIS-directed antibodies are present in sera from patients with autoimmune thyroid disease, and these antibodies also may affect NIS functional activity.

AB - In addition to physiologic, diagnostic, and therapeutic implications, the recently cloned and characterized sodium iodide symporter (NIS) also may play an important role in the pathogenesis of autoimmune thyroid disease. Sodium iodide symporter expression patterns characteristically are changed in autoimmune thyroid disease, including Graves' disease and Hashimoto's thyroiditis, which may be caused, in part, by the regulation of sodium iodide symporter expression of cytokines involved in the pathogenesis of autoimmune thyroid disease. Further, there is increasing evidence that NIS-directed antibodies are present in sera from patients with autoimmune thyroid disease, and these antibodies also may affect NIS functional activity.

UR - http://www.scopus.com/inward/record.url?scp=0034124974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034124974&partnerID=8YFLogxK

M3 - Review article

C2 - 10874536

AN - SCOPUS:0034124974

VL - 29

SP - 389

EP - 398

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 2

ER -